inflammatory diseases

troika

Novartis rides IgAN trioka to trial wins in rare kidney diseases

Atrasentan could be a potential competitor to Travere's Filspari, but the Novartis med doesn't appear to have an upper hand.

Angus Liu May 28, 2024 11:20am

Takeda

Takeda snags FDA nod for once-snubbed Eohilia to go after Sanofi

Feb 12, 2024 11:18am

Lilly

Delayed FDA nod moves Lilly into crowded ulcerative colitis field

Oct 27, 2023 11:10am

Tschudin

Novartis targets new fields—and CAR-T—for immunology growth

May 10, 2023 5:00pm

head to head against clash football helmets fight combat

Novartis, UCB set to battle it out in inflammatory skin disease

Apr 10, 2023 4:40pm

FDA

FDA authorizes InflaRx's anti-inflammation drug for severe COVID

Apr 4, 2023 5:12pm